Episurf Medical AB

Equities

EPIS B

SE0003491562

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Stockholm Other stock markets 06:07:23 02/07/2024 pm IST			5-day change	1st Jan Change
0.2275 ^SEK	+2.71%		-6.40%	-77.12%

24/04	Episurf Medical Announces Distributor Agreement with Depuy-Synthes	CI
24/04	Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Episurf Medical Signs Distribution Agreement for the Israeli Market with AMI Technologies Ltd

January 19, 2018 at 12:32 am IST

Episurf Medical announced that the Israeli Ministry of Health has approved Episurf Medical's Episealer® knee products for the Israeli market. The approval follows a review process. Episurf Medical further announced that the company has entered into a distribution agreement for the Israeli market with AMI Technologies Ltd.

Latest news about Episurf Medical AB

Episurf Medical Announces Distributor Agreement with Depuy-Synthes	24/04	CI
Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04	CI
Episurf Medical Plans SEK120 Million Rights Issue	22/04	MT
Episurf Medical AB Elects Jess Lonner as New Member of the Board of Directors	09/04	CI
Episurf Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	09/02	CI
Sweden's Episurf Medical Secures New Patents in Asia, South Africa	28/11	MT
Episurf Medical AB Receives Four Additional Patent Approval Notification	28/11	CI
Episurf Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	27/23/27	CI
Episurf Medical Announces 510(k) Submission for Big Toe Implant	20/23/20	CI
Episurf Members Announces Nomination Committee for Episurf Medical's Annual General Meeting in 2024	17/23/17	CI
Episurf Medical Announces Early Clinical Results from Episealer Talus Study Presented at Scientific Congress	28/23/28	CI
Episurf Medical Announces Prospective Episealer Talus Clinical Study	13/23/13	CI
Episurf Medical's New Knee Joint Implant System Scheduled For Surgery Use in US	23/23/23	MT
Episurf Medical AB Announces First Commercial Case in the US Has Been Scheduled for Surgery	23/23/23	CI
Episurf Announces Results from the Use of Episealer Accepted for Publication in Scientific Journal	31/23/31	CI
Episurf Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
Episurf Medical Wins Hospital Value Analysis Committee's Approval for Implant System	07/23/07	MT
Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
Episurf Medical Builds US Distributor Network for Episealer Patellofemoral System	11/23/11	MT
Episurf Medical Receives Another Granted Patent in India	02/23/02	CI
Episurf Medical Receives Another Notice of Allowance from the United States Patent and Trademark Office	01/23/01	CI
Episurf Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	17/23/17	CI
Episurf Medical AB Reports Earnings Results for the Full Year Ended December 31, 2022	17/23/17	CI
Episurf Medical AB Announces Dennis Stripe Not Stand for Re-Election as Chairman of the Board of Directors	13/23/13	CI
Episurf Medical AB Receives Notice of Allowance from the United States Patent and Trademark Office	02/23/02	CI

Chart Episurf Medical AB

Duration

Period

More charts

Company Profile

Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Companyâs product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide designed to attach to the kneeâs surface, as well as related surgical tools. The personalization of implants and instruments is based on magnetic resonance imaging (MRI) and enables less invasive treatment. The process of ordering and creation of patient-specific implants and surgical instruments is covered by software suite, microiFidelity, comprising microiClinic, microiDesign and microiManufacture. The main shareholder of the Company is Serendipity Ixora Fund AB.

Sector

Medical Equipment, Supplies & Distribution

Calendar

12/07/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Episurf Medical AB

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
EPISURF MEDICAL AB	-77.12%	13.56M
STRYKER CORPORATION	+12.37%	128B
SMITH & NEPHEW PLC	-10.34%	10.75B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-17.40%	7.19B
GLAUKOS CORPORATION	+47.72%	6.41B
INSPIRE MEDICAL SYSTEMS, INC.	-31.81%	4.12B
AXONICS, INC.	+8.15%	3.43B
ENOVIS CORPORATION	-20.83%	2.43B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-18.87%	1.9B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-25.13%	1.66B

Medical Devices & Implants